{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:23:41Z","timestamp":1794212621886,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001125","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"reference-count":148,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001125.pub2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T11:40:00Z","timestamp":1764070800000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cyproterone acetate for hirsutism"],"prefix":"10.1002","volume":"2025","author":[{"given":"Mushi J","family":"Matjila","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town; Groote Schuur Hospital; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Andre","family":"Le Roux","sequence":"additional","affiliation":[{"name":"Cape Fertility Clinic; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zephne M","family":"van der Spuy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town; Groote Schuur Hospital; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2265.1991.tb03489.x","article-title":"Cyproterone acetate for severe hirsutism: results of a double blind dose-ranging study","volume":"35","author":"Barth","year":"1991","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drosperinone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijgo.2004.06.003","article-title":"Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"87","author":"Beigi","year":"2004","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0015-0282(16)49873-0","article-title":"Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study","volume":"46","author":"Belisle","year":"1986","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate and drospirenone in participants with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TEN.0b013e3181a58772","article-title":"The effects of rosiglitazone, metformin and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome","volume":"19","author":"Cetinkalp","year":"2009","journal-title":"Endocrinologist"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jcem-63-4-1031","article-title":"Comparative effects of cyproterone acetate or a long acting gonadotrophin releasing hormone agonist in polycystic ovary disease","volume":"63","author":"Couzinet","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/01443619109013510","article-title":"Hirsutography: photographic measurement of linear hair growth in hirsute women during comparison of anti-androgen treatments","volume":"11","author":"Dixon","year":"1991","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0015-0282(16)58441-6","article-title":"Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"22","author":"Erenus","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(98)00486-5","article-title":"Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects","volume":"71","author":"Fruzetti","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09513599609012316","article-title":"Comparison of four different treatment regimens in hirsutism related to polycystic ovary syndrome","volume":"10","author":"G\u00f6kmen","year":"1996","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0012|cit12","first-page":"455","article-title":"Role of the combination spironolactone-norgestimate-estrogen in hirsute women with polycystic ovary syndrome","volume":"59","author":"Hagag","year":"2014","journal-title":"Journal of Reproductive Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001125.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or anti-androgen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/jc.2011-1671","article-title":"Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin","volume":"96","author":"Ib\u00e1\u0148ez","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1210\/jc.2013-1041","article-title":"Oral contraception versus insulin sensitization for 18 months in non-obese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity and menstrual irregularity","volume":"98","author":"Ib\u00e1\u0148ez","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00404-014-3217-5","article-title":"Comparison of two oral contraceptive forms containing cyproterone acetate and drosperinone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial","volume":"290","author":"Kahraman","year":"2014","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09546634.2010.519766","article-title":"Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens","volume":"23","author":"Kelekci","year":"2012","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(02)04927-0","article-title":"Use of cyproterone acetate, finasteride and spironalactone to treat idiopathic hirsutism","volume":"79","author":"Lumachi","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","article-title":"Comparison of sequential cyproterone acetate\/estrogen versus spironolactone \/oral contraceptive in the treatment of hirsutism","volume":"72","author":"O'Brien","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0015-0282(98)00414-2","article-title":"Prospective randomised study comparing the long-acting gonadotrophin-releasing hormone agonist triptorelin, flutamide and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism","volume":"71","author":"Pazos","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0022|cit22","first-page":"109","article-title":"Treatment of hirsutism in polycystic ovary syndrome with Diane, 50 mcg ethinyl estradiol and 2mg cyproterone acetate","volume":"9","author":"Saeed","year":"1993","journal-title":"Pakistan Journal of Medical Science"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironalactone as a single agent for long-term therapy of hirsute participants","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01542482","article-title":"Effects of anti-androgen estrogen treatment on sexual and endocrine parameters in hirsute women","volume":"17","author":"Adamopoulos","year":"1988","journal-title":"Archives of Sexual Behaviour"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000017849","article-title":"Oral contraceptives and cyproterone acetate in female acne treatment","volume":"196","author":"Beylot","year":"1998","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"14","key":"10.1002\/14651858.CD001125.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2169\/internalmedicine.48.2177","article-title":"The effect of ethinylestradiol (EE)\/cyproterone acetate (CA) and EE\/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS)","volume":"48","author":"Bilgir","year":"2009","journal-title":"Internal Medicine (Tokyo, Japan)"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0015-0282(98)00061-2","article-title":"The addition of dexamethazone to antiandrogen therapy for hirsutism prolongs the duration of remission","volume":"69","author":"Carmina","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13625189809051408","article-title":"Effects of bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a two year follow-up","volume":"3","author":"Castelo-Branco","year":"1998","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.atherosclerosis.2007.03.002","article-title":"The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome","volume":"196","author":"Charitidou","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0030|cit30","first-page":"124","article-title":"Effects of Diane-35 and Marvelon in women with polycystic ovary syndrome: a randomised, controlled trial","volume":"32","author":"Cheng","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.14310\/horm.2002.1553","article-title":"The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers","volume":"13","author":"Christakou","year":"2014","journal-title":"Hormones"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpag.2013.09.011","article-title":"A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome","volume":"27","author":"Chung","year":"2014","journal-title":"Journal of Pediatric and Adolescent Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD001125.pub2-BIB0033|cit33","first-page":"783","article-title":"Acceptance, tolerance and effects on quality of life of treatment of hiruste women with cyproterone acetate. Comparison of associated treatment with oral estradiol to transdermal estradiol","volume":"22","author":"Consoli","year":"1994","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome","volume":"900","author":"Creatsas","year":"2006","journal-title":"Annals New York Academy of Sciences"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0035|cit35","first-page":"300","article-title":"Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol","volume":"-","author":"Cremoncini","year":"1976","journal-title":"International Symposium on Androgens and Anti-Androgens"},{"issue":"10","key":"10.1002\/14651858.CD001125.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1210\/jc.2012-1754","article-title":"Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163 receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue","volume":"97","author":"D\u00edaz","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabet.2015.10.004","article-title":"Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess","volume":"42","author":"Diaz","year":"2016","journal-title":"Diabetes & Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD001125.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomised controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016349009021041","article-title":"Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms","volume":"69","author":"Erkkola","year":"1990","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/2277-9175.148236","article-title":"The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: a randomized clinical trial","volume":"3","author":"Faghihi","year":"2014","journal-title":"Advanced Biomedical Research"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/09513590.2015.1101441","article-title":"Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin","volume":"32","author":"Feng","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"12","key":"10.1002\/14651858.CD001125.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01660957","article-title":"Therapy for women with hirsutism with adrenal enzyme defects of enzyme biosynthesis: compared with dexamethazone combined with cyproterone acetate","volume":"68","author":"Frank-Raue","year":"1990","journal-title":"Klinische Wochenschrift"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513599609097901","article-title":"Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomised controlled trial","volume":"10","author":"Grigoriou","year":"1996","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.134.4.459","article-title":"Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial","volume":"134","author":"Gruber","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"48","key":"10.1002\/14651858.CD001125.pub2-BIB0045|cit45","first-page":"2180","article-title":"The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate)","volume":"26","author":"Grund","year":"1975","journal-title":"Die Medizinische Welt"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0046|cit46","first-page":"522","article-title":"Cyproterone acetate as initial treatment and maintenance therapy for hirsutism","volume":"109","author":"Holdaway","year":"1985","journal-title":"Acta Endocrinologica"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0015-0282(16)54240-X","article-title":"Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta estradiol","volume":"55","author":"Jasonni","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12325-008-0039-5","article-title":"Comparison of the clinical efficacy of flutamide and spironalactone plus ethinyloestradiol\/cyproterone acetate in the treatment of hirsutism: a randomised controlled study","volume":"25","author":"Karakurt","year":"2008","journal-title":"Advances in Therapy"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00404-009-1051-y","article-title":"Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome","volume":"281","author":"Kebapcilar","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0015-0282(97)00427-5","article-title":"Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism","volume":"69","author":"Kelestimur","year":"1997","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0051|cit51","first-page":"e203","article-title":"Body composition analysis, inflammatory markers and insulin sensitivity in PCOS patients at diagnosis and after treatment","volume":"Suppl 1","author":"Kotwal","year":"2015","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A systematic review of commonly used medical treatments for hirsutism in women","volume":"68","author":"Koulori","year":"2008","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"45","key":"10.1002\/14651858.CD001125.pub2-BIB0054|cit54","first-page":"1922","article-title":"Therapy of androgenisation symptoms","volume":"72","author":"Lachnit-Fixson","year":"1977","journal-title":"Medizinische Klinik"},{"issue":"Suppl","key":"10.1002\/14651858.CD001125.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00016347909157227","article-title":"The development and evaluation of an ovulation inhibitor (Diane) containing an antiandrogen","volume":"88","author":"Lachnit-Fixson","year":"1979","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/jog.12543","article-title":"Comparison of desogestrel\/ethinyl estradiol plus spironolactone versus cyproterone acetate\/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomised controlled trial","volume":"41","author":"Leelaphiwat","year":"2015","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD001125.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1210\/jc.2011-2744","article-title":"An approach to the patient with hirsutism","volume":"97","author":"Loriaux","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(16)53213-0","article-title":"Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects","volume":"53","author":"Marcondes","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001125.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.dsx.2015.10.001","article-title":"A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome","volume":"10","author":"Mhao","year":"2016","journal-title":"Diabetes & Metabolic Syndrome"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2008-1036425","article-title":"Medium dose cyproterone acetate therapy for women with moderate hyperandrogenism","volume":"44","author":"Moltz","year":"1984","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"9","key":"10.1002\/14651858.CD001125.pub2-BIB0063|cit63","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomised study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomised study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD001125.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-M\u00fcllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"Panidis","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9378(86)90410-2","article-title":"Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese participants with polycystic ovaries","volume":"154","author":"Pasquali","year":"1986","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)54291-5","article-title":"Long term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives","volume":"55","author":"Porcile","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/09513599709152569","article-title":"Treatment of androgen excess in females: yesterday, today and tomorrow","volume":"11","author":"Pucci","year":"1997","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0069|cit69","first-page":"1057","article-title":"Administration of cyproterone acetate and natural estrogens in the treatment of hirsutism","volume":"20","author":"Pugeat","year":"1991","journal-title":"Journal of Obstetrics and Gynaecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0070|cit70","first-page":"387","article-title":"Action mechanisms of cyproterone acetate in the treatment of hirsutism","volume":"44","author":"Rigaud","year":"1983","journal-title":"Annals of Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-8529(05)70077-3","article-title":"Antiandrogen treatment of polycystic ovary syndrome","volume":"28","author":"Rittmaster","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0015-0282(03)02162-9","article-title":"Sibutramine has a positive effect on clinical and metabolic parameters in obese participants with polycystic ovary syndrome","volume":"80","author":"Sabuncu","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350769","article-title":"Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism","volume":"21","author":"Sahin","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(00)01764-7","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"75","author":"Sahin","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0075|cit75","first-page":"125","article-title":"Parenteral and oral cyproterone acetate treatment in severe hirsutism","volume":"24","author":"Schmidt","year":"1987","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0076|cit76","first-page":"73","article-title":"Comparison of the efficacy of anti-androgenic regimens consisting of spironalactone, Diane 35 and cyproterone acetate in hirsutism","volume":"57","author":"Sert","year":"2003","journal-title":"Acta Medica Okayama"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0077|cit77","first-page":"1571","article-title":"Effect of combined oral contraceptives and cyproterone acetate-ethinyl estradiol combination on metabolic syndrome in polycystic ovarian syndrome (PCOS)","volume":"9","author":"Singhal","year":"2022","journal-title":"European Journal of Molecular and Clinical Medicine"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Antiandrogens for the treatment of hirsutism: a systematic review and metaanalysis of randomised controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"19","key":"10.1002\/14651858.CD001125.pub2-BIB0080|cit80","first-page":"20","article-title":"The treatment of hirsutism: experience with cyproterone acetate and spironolactone","volume":"26","author":"Thomas","year":"1985","journal-title":"Australian Journal of Dermatology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0081|cit81","unstructured":"van der Spuy ZM Nugent FA The management of hirsutism in PCOS using GnRH agonist analogue therapy Unpublished data 1995"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0082|cit82","first-page":"260","article-title":"An open randomised comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long term treatment of hirsutism","volume":"41","author":"Vegetti","year":"1996","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomised trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"84","author":"Venturoli","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(88)90083-2","article-title":"Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women","volume":"38","author":"Vermeulen","year":"1988","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0015-0282(16)57418-4","article-title":"17 beta estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate","volume":"63","author":"Vexiau","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0086|cit86","first-page":"481","article-title":"Hormonal treatment effectivity in hyperandrogenic syndrome","volume":"75","author":"Visnovsk\u00fd","year":"2010","journal-title":"Ceska\u0301 Gynekologie"},{"issue":"8","key":"10.1002\/14651858.CD001125.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4103\/0366-6999.179783","article-title":"Comparison of drospirenone- with cyproterone acetate-containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders: a prospective randomized control trial","volume":"129","author":"Song","year":"2016","journal-title":"Chinese Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD001125.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome","volume":"24","author":"Wu","year":"2008","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-0960.1998.tb01271.x","article-title":"Hirsutes II: treatment","volume":"39","author":"Young","year":"1998","journal-title":"Australian Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humrep\/dez255","article-title":"A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial","volume":"35","author":"Amiri","year":"2020","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7","key":"10.1002\/14651858.CD001125.pub2-BIB0091|cit91","first-page":"18","article-title":"Effectiveness of low-dose ethinylestradiol\/cyproterone acetate and ethinylestradiol\/desogestrel with and without metformin on hirsutism in polycystic ovary syndrome: a randomized, double-blind, triple-dummy study","volume":"13","author":"Fonseka","year":"2020","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jogoh.2018.10.006","article-title":"Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: a randomized controlled trial","volume":"48","author":"Sahu","year":"2019","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD001125.pub2-BIB0093|cit93","first-page":"917","article-title":"Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol\/cyproterone and desogestrel\/ethinyl oestradiol tablets in women with polycystic ovary syndrome","volume":"38","author":"Zhang","year":"2018","journal-title":"Journal of Southern Medical University"},{"issue":"6543","key":"10.1002\/14651858.CD001125.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"British Medical Journal Clinical Research Edition"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS Consensus Workshop Group","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1-4","key":"10.1002\/14651858.CD001125.pub2-BIB0096|cit96","first-page":"177","article-title":"Effects of anti-androgen treatment on the sexuality of women with hyperandrogenism","volume":"42","author":"Appelt","year":"1984","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/9783110866902-013","volume-title":"Antiandrogen-Estrogen Therapy for Signs of Androgenization","author":"Ashton","year":"1987"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/edrv-5-4-498","article-title":"Female hirsutism: pathophysiological considerations and therapeutic implications","volume":"5","author":"Biffignandi","year":"1984","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000194.pub2","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1989.tb08208.x","article-title":"Most women with acne have polycystic ovaries","volume":"121","author":"Bunker","year":"1989","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 participants","volume":"30","author":"Conway","year":"1989","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.fertnstert.2011.08.022","article-title":"Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?","volume":"96","author":"Cook","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-32-6-737","article-title":"Androgen metabolism in human skin","volume":"32","author":"Flamigni","year":"1971","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective","volume":"31","author":"Franks","year":"1989","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jfprhc-2011-100175","article-title":"The investigation and management of hirsutism","volume":"38","author":"Franks","year":"2013","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1521-6934(04)00106-3","article-title":"Current recommendations for the diagnostic evaluation and follow-up of participants presenting with symptomatic polycystic ovary syndrome","volume":"18","author":"Fraser","year":"2004","journal-title":"Best Practice and Research Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0110|cit110","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2019"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0022-4731(75)90311-8","article-title":"Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism","volume":"6","author":"Hammerstein","year":"1975","journal-title":"Journal of Steroid Biochemistry"},{"issue":"1B","key":"10.1002\/14651858.CD001125.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0022-4731(83)90223-6","article-title":"Antiandrogens in the treatment of acne and hirsutism","volume":"19","author":"Hammerstein","year":"1983","journal-title":"Journal of Steroid Biochemistry"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0113|cit113","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated August 2017). Cochrane, 2017 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.2.0"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0114|cit114","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"issue":"8","key":"10.1002\/14651858.CD001125.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","volume":"96","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD001125.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2133.1981.tb00979.x","article-title":"Effect of cyproterone acetate on rate of hair growth in hirsute women","volume":"105","author":"Jones","year":"1981","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD001125.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.fertnstert.2011.05.048","article-title":"Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0119|cit119","first-page":"1716","article-title":"Sequential estrogen-progestin addition to gonadotrophin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study","volume":"79","author":"Lemay","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD001125.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1210\/jc.2011-2744","article-title":"An approach to the patient with hirsutism","volume":"97","author":"Loriaux","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0121|cit121","first-page":"91","article-title":"The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women","volume":"100","author":"Lunnell","year":"1982","journal-title":"Acta Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0122|cit122","first-page":"177","article-title":"The prevalence of \"hirsutism\" in young women","volume":"42","author":"McKnight","year":"1964","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-52-2-338","article-title":"Androgen receptor in human skin cytosol","volume":"52","author":"Mowszowicz","year":"1981","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-56-2-320","article-title":"Dihydrotestosterone stimulates 5-alpha reductase activity in pubic skin fibroblasts","volume":"56","author":"Mowszowicz","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0015-0282(00)00470-2","article-title":"A prospective randomized trial comparing flutamide (250mg\/d) and finasteride (5mg\/d) in the treatment of hirsutism","volume":"73","author":"Muderris","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/9783110866902-004","volume-title":"Anti-Androgen Estrogen Therapy for Signs of Androgenisation","author":"Neumann","year":"1987"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1515\/9783110866902-022","volume-title":"Anti-Androgen Estrogen Therapy for Signs of Androgenisation","author":"Nurnberger","year":"1987"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.contraception.2011.03.002","article-title":"A prospective randomized trial comparing low-dose ethinyl estradiol and drosperinone 24\/4 combined oral contraceptive vs ethinyl estradiol and drosperinone 21\/7 combined oral contraceptive in the treatment of hirsutism","volume":"84","author":"Oner","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2009.12.007","article-title":"Recommendations for investigation of hyperandrogenism","volume":"71","author":"Pugeat","year":"2010","journal-title":"Annales d'Endocrinologie"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0950-3552(88)80045-2","article-title":"Anti-androgens in gynaecological practice","volume":"2","author":"Reed","year":"1988","journal-title":"Baillieres Clinical Obstetrics & Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD001125.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2265.1984.tb00088.x","article-title":"Androgen levels during cyproterone acetate in ethinyl estradiol treatment of hirsutism","volume":"20","author":"Rubens","year":"1984","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1523-1747.ep12551679","article-title":"Human hair cycle","volume":"54","author":"Saitoh","year":"1970","journal-title":"Journal of Dermatology Investigation"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2133.1985.tb02038.x","article-title":"The hair cycle on the human thigh and upper arm","volume":"113","author":"Seago","year":"1985","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40267-020-00799-7","article-title":"Ketoconazole in Cushing's syndrome: a profile of its use","volume":"37","author":"Shirley","year":"2021","journal-title":"Drugs and Therapy Perspectives"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001125.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"38","author":"Teede","year":"2023","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD001125.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0140|cit140","first-page":"975","article-title":"Evolution of progestins","volume":"47","author":"Thorneycroft","year":"2002","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0300-595X(86)80030-5","article-title":"Treatment of hirsutism with spironolactone","volume":"15","author":"Tremblay","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1002\/14651858.CD001125.pub2-BIB0143|cit143","first-page":"90","article-title":"Nutrition and reproduction","volume":"4","author":"Spuy","year":"1992","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jcem-71-2-335","article-title":"Ketoconazole therapy for women with acne and\/or hirsutism","volume":"71","author":"Venturoli","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"18","key":"10.1002\/14651858.CD001125.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM198010303031805","article-title":"Treatment of hirsute women with cimetidine","volume":"300","author":"Vigersky","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0146|cit146","first-page":"12","article-title":"Effect of an oral contraceptive on adrenal and ovarian androgenic steroids","volume":"63","author":"Wiebe","year":"1984","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001125.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"26380","DOI":"10.1074\/jbc.M300688200","article-title":"The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis","volume":"278","author":"Wood","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD001125.pub2-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001125","article-title":"Cyproterone acetate for hirsutism","author":"Spuy","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:47:55Z","timestamp":1794210475000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001125.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":148,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001125.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}